Compare ETON & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | AMC |
|---|---|---|
| Founded | 2017 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.7M | 786.8M |
| IPO Year | 2018 | 2007 |
| Metric | ETON | AMC |
|---|---|---|
| Price | $25.88 | $1.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $39.33 | $2.03 |
| AVG Volume (30 Days) | 468.4K | ★ 26.6M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $79,950,000.00 | ★ $4,848,900,000.00 |
| Revenue This Year | $40.90 | $10.60 |
| Revenue Next Year | $47.23 | $4.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 104.94 | 4.57 |
| 52 Week Low | $13.09 | $0.93 |
| 52 Week High | $27.19 | $4.08 |
| Indicator | ETON | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 68.66 | 74.41 |
| Support Level | $16.79 | $0.93 |
| Resistance Level | N/A | $1.54 |
| Average True Range (ATR) | 1.31 | 0.10 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 73.61 | 97.12 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.